UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$324M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$241M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$150M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$142M |
| 5 |
UBS Group
UBS
|
+$140M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$630M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$608M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$368M |
| 4 |
Tesla
TSLA
|
+$339M |
| 5 |
Amazon
AMZN
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.88% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.52% |
| 4 | Consumer Discretionary | 4.99% |
| 5 | Industrials | 4.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
Idacorp
IDA
$8.11B
| $963K | ﹤0.01% |
9,720
-8,922
| -48% | -$973K |
|
3777
KFA Mount Lucas Managed Futures Index Strategy ETF
KMLM
$414M
| $963K | ﹤0.01% |
25,098
+15,406
| +159% | +$550K |
|
|
SFBS
3778
ServisFirst Bancshares
SFBS
$4.88B
| $963K | ﹤0.01% |
12,034
+4,788
| +66% | +$404K |
|
3779
Invesco Dorsey Wright Consumer Staples Momentum ETF
PSL
$83.1M
| $960K | ﹤0.01% |
12,822
+7,642
| +148% | +$617K |
|
3780
Ginkgo Bioworks
DNA
$506M
| $956K | ﹤0.01% |
7,660
+6,044
| +374% | +$720K |
|
3781
Integra LifeSciences
IART
$1.35B
| $956K | ﹤0.01% |
22,581
+9,109
| +68% | +$467K |
|
3782
Lennar Class B
LEN.B
$20.8B
| $955K | ﹤0.01% |
16,877
+2,070
| +14% | +$126K |
|
3783
Pediatrix Medical
MD
$2.12B
| $953K | ﹤0.01% |
57,720
+48,195
| +506% | +$970K |
|
|
FPI
3784
Farmland Partners
FPI
$425M
| $952K | ﹤0.01% |
75,121
-98,249
| -57% | -$1.4M |
|
3785
WD-40
WDFC
$3.13B
| $952K | ﹤0.01% |
5,420
-838
| -13% | -$157K |
|
|
ORGN
3786
DELISTED
Origin Materials
ORGN
| $951K | ﹤0.01% |
6,147
-180
| -3% | -$31.9K |
|
3787
PUT
Peloton Interactive
PTON
$2.46B
| $951K | ﹤0.01% |
137,300
-100,000
| -42% | -$1.02M |
|
|
AKTS
3788
DELISTED
Akoustis Technologies Inc
AKTS
| $951K | ﹤0.01% |
320,094
+12,746
| +4% | +$51.8K |
|
|
AMRN
3789
Amarin Corp
AMRN
$296M
| $950K | ﹤0.01% |
43,556
-798
| -2% | -$21.4K |
|
3790
PUT
Okta
OKTA
$26.1B
| $950K | ﹤0.01% |
16,700
-38,900
| -70% | -$3.35M |
|
|
LSXMA
3791
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $950K | ﹤0.01% |
33,927
-18,270
| -35% | -$541K |
|
3792
First Trust Dow Jones Select MicroCap Index Fund
FDM
$269M
| $949K | ﹤0.01% |
18,984
-3,060
| -14% | -$170K |
|
|
VIVO
3793
DELISTED
Meridian Bioscience Inc
VIVO
| $948K | ﹤0.01% |
30,067
+23,059
| +329% | +$747K |
|
3794
ACI Worldwide
ACIW
$5.27B
| $946K | ﹤0.01% |
45,259
-31,065
| -41% | -$772K |
|
3795
Graham Holdings Company
GHC
$4.97B
| $944K | ﹤0.01% |
1,755
-60
| -3% | -$34.3K |
|
3796
Signet Jewelers
SIG
$3.68B
| $943K | ﹤0.01% |
16,482
+2,771
| +20% | +$167K |
|
3797
PUT
Virgin Galactic
SPCE
$498M
| $942K | ﹤0.01% |
10,000
-9,430
| -49% | -$1.21M |
|
3798
iShares Core Conservative Allocation ETF
AOK
$791M
| $941K | ﹤0.01% |
28,850
-3,441
| -11% | -$119K |
|
3799
Dr. Reddy's Laboratories
RDY
$10.4B
| $940K | ﹤0.01% |
89,755
+11,990
| +15% | +$128K |
|
3800
AbCellera Biologics
ABCL
$2.99B
| $938K | ﹤0.01% |
94,838
+53,483
| +129% | +$587K |
|
Similar funds
UBS Group's Q3 2022 Portfolio in Review
As of Q3 2022, UBS Group held 11,885 positions worth $228B, down 6.3% from $244B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q3 2022 filing shows 1,175 new, 4,825 increased, 3,846 reduced and 1,024 closed positions. Its largest new stake was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M. The largest sale was iShares MSCI ACWI ETF, an estimated $630M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q3 2022 buy was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $324M increase.
- UBS Group's biggest Q3 2022 reduction was iShares MSCI ACWI ETF, cutting an estimated $630M.
- UBS Group fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $111M.
- UBS Group's ten largest holdings make up 14% of its $228B portfolio in Q3 2022.
- UBS Group opened 1,175 new positions and closed 1,024 in Q3 2022.
- UBS Group's portfolio value fell 6.3% quarter-over-quarter to $228B.
Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.